StockNews.com initiated coverage on shares of Retractable Technologies (NYSE:RVP – Free Report) in a research report report published on Tuesday. The brokerage issued a hold rating on the stock.
Retractable Technologies Price Performance
RVP stock opened at $0.60 on Tuesday. The firm has a 50 day simple moving average of $0.74 and a two-hundred day simple moving average of $0.95. The company has a debt-to-equity ratio of 0.01, a current ratio of 8.57 and a quick ratio of 5.92. The stock has a market cap of $17.93 million, a PE ratio of -1.11 and a beta of 2.06. Retractable Technologies has a one year low of $0.56 and a one year high of $1.34.
Insider Buying and Selling at Retractable Technologies
In other Retractable Technologies news, CEO Thomas J. Shaw acquired 71,422 shares of the business’s stock in a transaction dated Friday, September 20th. The stock was bought at an average price of $0.82 per share, with a total value of $58,566.04. Following the purchase, the chief executive officer now owns 14,743,907 shares of the company’s stock, valued at approximately $12,090,003.74. This trade represents a 0.49 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Insiders have bought 179,649 shares of company stock worth $143,163 over the last 90 days. Corporate insiders own 55.00% of the company’s stock.
Institutional Trading of Retractable Technologies
About Retractable Technologies
Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.
Featured Stories
- Five stocks we like better than Retractable Technologies
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- Can BioMarin Stock Live Up to Wall Street’s High Expectations?
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Why Palo Alto Networks’ Multi-Year Uptrend Is Far From Over
- Low PE Growth Stocks: Unlocking Investment Opportunities
- 3 Rock-Solid Buying Opportunities in the Market Right Now
Receive News & Ratings for Retractable Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Retractable Technologies and related companies with MarketBeat.com's FREE daily email newsletter.